FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 4, 1999, Pages 763-775

  Logsdon, Mark D ^a   Eifel, Patricia J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cervix cancer; Radiotherapy; Stage IIIB

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; HYDROXYUREA;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA;

EID: 0032945337     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00482-9     Document Type: Article

References (44)

1. Barillot I., Horiot J.C., Pigneux J., et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone A French Cooperative Study: Update and multivariate analysis of prognostics factors . Int J Radiat Oncol Biol Phys. 38:1997;969-978.
2. Fyles A.W., Pintilie M., Kirkbride P., et al. Prognostic factors in patients with cervix cancer treated by radiation therapy Results of a multiple regression analysis . Radiother Oncol. 35:1995;107-117.
3. Kovalic J.J., Perez C.A., Grigsby P.W., et al. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 21:1991;905-910.
4. Lanciano R.M., Martz K., Coia L.R., et al. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys. 20:1991;95-100.
5. Montana G.S., Fowler W.C., Varia M.A., et al. Carcinoma of the cervix, Stage III. Results of radiation therapy. Cancer. 57:1986;148-154.
6. Boulware R.J., Caderao J.B., Delclos L., et al. Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancers. Int J Radiat Oncol Biol Phys. 5:1979;333-338.
7. Maor M.H., Gillespie B.W., Peters L.J., et al. Neutron therapy in cervical cancer Results of a phase III RTOG study . Int J Radiat Oncol Biol Phys. 14:1988;885-891.
8. Smith J.P., Randall G.E., Castro J.R., et al. Hypogastric artery infusion and radiation therapy for advanced squamous cell carcinoma of the cervix. Am J Roentgenol. 114:1972;110-115.
9. Morris M., Eifel P.J., Burke T.W., et al. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 57:1995;72-78.
10. Delclos L. Gynecologic cancers: Pelvic examination and treatment planning. Levitt S., Tapley N. Technological basis of radiation therapy: Practical clinical applications. 1984;193-227 Lea & Febiger, Philadelphia.
11. Eifel P.J., Morris M., Delclos L., et al. Radiation therapy for cervical carcinoma. Dilts P.V. Jr, Sciarra J.J. Gynecology and obstetrics. 1993;1-25 JB Lippincott Co, Philadelphia.
12. Fletcher G.H., Hamberger A.D. Squamous cell carcinoma of the uterine cervix. In: Treatment technique according to size of the cervical lesion and extension. Fletcher G.H. Textbook of radiotherapy. 1980;720-778 Lea & Febiger, Philadelphia.
13. Jampolis S., Andras J., Fletcher G.H. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology. 15:1975;681-685.
14. Eifel P.J., Levenback C., Wharton J.T., et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 32:1995;1289-1300.
15. Fyles A., Keane T.J., Barton M., et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 25:1992;273-279.
16. Girinski T., Rey A., Roche B., et al. Overall treatment time in advanced cervical carcinomas A critical parameter in treatment outcome . Int J Radiat Oncol Biol Phys. 27:1993;1051-1056.
17. Lanciano R.M., Pajak T.F., Martz K., et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation A Patterns-of-Care Study . Int J Radiat Oncol Biol Phys. 25:1993;391-397.
18. Petereit D.G., Sarkaria J.N., Chappell R., et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 32:1995;1301-1307.
19. Fletcher G.H. Textbook of radiotherapy. 1966;Lea & Febiger, Philadelphia.
20. Benstead K., Cowie V.J., Blair V., et al. Stage III carcinoma of cervix. The importance of increasing age and extent of parametrial involvement. Radiother Oncol. 5:1986;271-276.
21. League of Nations Health Organization Inquiry into the results of radiotherapy in cancer of the uterus. Atlas illustrating the division of cancer of the uterine cervix into four stage according to the anatomo-clinical extent of growth. Stockholm: Kungl. Boktryckeriet P. A. Norstedt & Söner; 1938.
22. Volterrani F., Lombardi F. Long term results of radium therapy in cervical cancer. Int J Radiat Oncol Biol Phys. 6:1980;565-570.
23. International Federation of Gynecology and Obstetrics Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand. 50:1971;1-12.
24. Arthur D., Kaufman N., Schmidt-Ullrich R., Kavanagh B., et al. Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 31:1995;743-751.
25. Chao K.S.C., Leung W.M., Grigsby P.W., et al. The clinical implications of hydronephrosis and the level of ureteral obstruction in stage IIIB cervical cancer. Int J Radiat Oncol Biol Phys. 40:1998;1095-1100.
26. Hopkins M.P., Morley G.W. Prognostic factors in advanced stage squamous cell cancer of the cervix. Cancer. 1993:1993;2389-2393.
27. Eifel P.J., Morris M., Wharton J.T., et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 29:1994;9-16.
28. Horiot J.C., Pigneux J., Pourquier H., et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines A French cooperative study of 1383 cases . Int J Radiat Oncol Biol Phys. 14:1988;605-611.
29. Chao C., Williamson J.F., Grigsby P.W., et al. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 40:1998;397-403.
30. Aristizabal S.A., Valencia A., Ocampo G., et al. Interstitial parametrial irradiation in cancer of the cervix stage IIB-IIIB. Endocuriether Hyperther Oncol. 6:1985;41-48.
31. Martinez A., Edmundson G.K., Cox R.S., et al. Combination of external beam irradiation and multiple-site perineal applicator (MUPIT) for treatment of locally advanced or recurrent prostatic, anorectal, and gynecologic malignancies. Int J Radiat Oncol Biol Phys. 11:1985;391-398.
32. Syed A.M.N., Puthwala A.A., Neblett D., et al. Transperineal interstitial-intracavitary "Syed-Neblett" applicator in the treatment of carcinoma of the uterine cervix. Endocuriether Hyperther Oncol. 2:1986;1-13.
33. Hughes-Davies L., Silver B., Kapp D. Parametrial interstitial brachytherapy for advanced or recurrent pelvic malignancy The Harvard/Stanford experience . Gynecol Oncol. 58:1995;24-27.
34. Monk B.J., Tewari K., Burger R.A., et al. A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer. Gynecol Oncol. 67:1997;241-247.
35. Eisbruch A., Johnston C.M., Martel M.K., et al. Customized gynecologic interstitial implants CT-based planning, dose evaluation, and optimization aided by laparotomy . Int J Radiat Oncol Biol Phys. 40:1998;1087-1093.
36. Bush R. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys. 12:1986;2047-2050.
37. Girinski T., Pejovic-Lenfant M., Bourhis J., et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy Results of a retrospective study of 386 patients . Int J Radiat Oncol Biol Phys. 16:1989;37-42.
38. Chauvergne J., Rohart J., Héron J.F., et al. Essai randomisé de chimiothérapie initiale dans 151 carcinomes du col utérin localement étendus (T2b-N1, T3b, MO). Bull Cancer (Paris). 77:1990;1007-1024.
39. Leborgne F., Leborgne J.H., Doldán R., et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix A pilot study and phase III randomized trial . Int J Radiat Oncol Biol Phys. 37:1997;343-350.
40. Souhami L., Gil R., Allan S., et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in Stage IIIB carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 9:1991;970-997.
41. Tattersall M.H.N., Larvidhaya V., Vootiprux V., et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Am J Clin Oncol. 13:1995;444-451.
42. Tattersall M.H.N., Ramirez C., Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2:1992;244-251.
43. Hreshchyshyn M.M., Aron B.S., Boronow R.C., et al. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys. 5:1979;317-322.
44. Rose P.G., Bundy B., Thigpen T., et al. Significant preliminary results of a phase III randomized study of concomitant chemoradiation with hydroxyurea vs hydroxyurea, 5-FU infusion, and bolus cisplatin (HFC) vs. weekly cisplatin in advanced cervical cancer, a GOG study. Gynecol Oncol. 68:1998;104.